Sapna Srivastava

About Sapna Srivastava

Sapna Srivastava is a director at Nuvalent.

Form D filings name Sapna Srivastava as a director at Alumis and an executive officer at eGenesis.

Sapna Srivastava reports to the SEC as a director or officer of 9 public companies, including Alumis (ALMS), Aura Biosciences (AURA) and Tourmaline Bio (TRML).

Sapna Srivastava first appears on SEC filings in 2013.

Experience

This experience comes from SEC filings. The years are when the filings name Sapna Srivastava in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Sapna Srivastava works with at each company, as listed on that company's latest Form D.

eGenesis, Inc. · Form D, Mar 10, 2021

PS

Paul Sekhri

President & CEO, director

KF

Kathleen Fanning

Director

PH

Peter Hanson

Executive officer

MC

Michael Curtis

Executive officer

SG

Steven Gillis

Director

JS

Julie Sunderland

Director

IC

Isaac Ciechanover

Director

AW

Albert Wiegman

Director

LI

Lucio Iannone

Director

Mark Pruzanski

Director

SS

Sarah Schlesinger

Director

Sources

1. SECAlumis Inc. Form D, filed Jul 24, 2024
2. SECeGenesis, Inc. Form D, filed Mar 10, 2021
3. SECForms 3, 4 and 5 filed by Sapna Srivastava (SEC filer 1569226)